Kiricuta I, Frenkel Z, Munteanu S
Arch Geschwulstforsch. 1978;48(6):565-8.
The main fractions of 17-ketosteroids were estimated in 102 women with breast cancer. Sixty two patients were cases with rapid evolution (malignant evolutive push) or very rapid evolution (inflammatory breast carcinoma). The mean ethiocholanolone levels and partially androsterone levels were significantly decreased in patients with rapid evolution in comparison with the corresponding values found in patients with breast cancer of slow growth.
对102例乳腺癌女性患者的17-酮类固醇主要组分进行了评估。62例患者为快速进展（恶性进展性推动）或极快速进展（炎性乳腺癌）病例。与生长缓慢的乳腺癌患者的相应值相比，快速进展患者的平均本胆烷醇酮水平以及部分雄酮水平显著降低。
